Alnylam presents vutrisiran and zilebesiran data at ESC 2026

Go back to Alnylam presents vutrisiran and zilebesiran data at ESC 2026
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 244.32 +4.76 (1.99%)
Previous Close $239.56    52 Week High $109.10 
Open $240.37    52 Week Low $31.38 
Day High $247.10    P/E N/A 
Day Low $237.97    EPS $-1.45 
Volume 1,152,873